QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wu, K. Articles by Giovannucci, E. L. Search for Related Content PubMed PubMed Citation Articles by Wu, K. Articles by Giovannucci, E. L.

---

Nutritional Epidemiology

Variations in Plasma Lycopene and Specific Isomers over Time in a Cohort of U.S. Men

Kana Wu^*,2, Steven J. Schwartz, Elizabeth A. Platz^**, Steven K. Clinton, John W. Erdman, Jr., Mario G. Ferruzzi, Walter C. Willett^*,,# and Edward L. Giovannucci^*,,#

^* Department of Nutrition, Harvard School of Public Health, Boston, MA; Department of Food Science and Technology, The Ohio State University, Columbus, OH; ^** Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD; Division of Hematology and Oncology, Department of Internal Medicine and Comprehensive Cancer Center, The Ohio State University, Columbus, OH; Division of Nutritional Sciences, University of Illinois, Urbana, IL; Department of Epidemiology, Harvard School of Public Health, Boston, MA; and ^# Channing Laboratory, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA

²To whom correspondence should be addressed. E-mail: kana.wu{at}channing.harvard.edu.

Epidemiologic and laboratory studies suggest a possible role for tomato products, a rich source of the carotenoid lycopene, in the prevention of certain cancers and cardiovascular disease. Lycopene is consumed primarily as the all-trans-isomer, but the majority of lycopene in blood and tissue exists as a variety of cis-isomers. Specific isomers may be involved in different biological reactions, and patterns of isomers may provide insight into the risk or pathogenesis of disease processes. Total lycopene concentration and the concentrations of the cis- and trans-lycopene isomers were measured by HPLC in plasma samples taken 3–4 y apart from 144 mostly nonsmoking male participants in the Health Professionals Follow-up Study. Correlations between plasma concentrations determined 3–4 y apart ranged from 0.55 (all-trans-isomer) to 0.70 (cis-isomer 5 -cis) (P < 0.001). For total lycopene, the correlation was 0.63 (P < 0.001). Total cis-lycopene contributed 67% of total lycopene (range 50–79%). At each time point, the various lycopene isomer concentrations were highly correlated with one another with Spearman correlation coefficients ranging from 0.90 to 0.99 (P < 0.001). Plasma concentrations of total lycopene and its most abundant isomers in samples taken 3–4 y apart were strongly correlated, indicating that dietary patterns and metabolic processes defining lycopene concentrations are stable over time. Because the patterns of lycopene isomers showed limited between-person variability, our results suggest that measuring specific lycopene isomers in epidemiologic studies may not provide additional information beyond that provided by total lycopene concentration. Single plasma samples quantitating plasma lycopene are a valid predictor of long-term exposure for epidemiologic studies.

KEY WORDS: • lycopene • isomers • reproducibility

This article has been cited by other articles:

				B. Mikhak, D. J. Hunter, D. Spiegelman, E. A. Platz, K. Wu, J. W. Erdman Jr, and E. Giovannucci Manganese superoxide dismutase (MnSOD) gene polymorphism, interactions with carotenoid levels and prostate cancer risk Carcinogenesis, December 1, 2008; 29(12): 2335 - 2340. [Abstract] [Full Text] [PDF]

				X. Liu, J. D. Allen, J. T. Arnold, and M. R. Blackman Lycopene inhibits IGF-I signal transduction and growth in normal prostate epithelial cells by decreasing DHT-modulated IGF-I production in co-cultured reactive stromal cells Carcinogenesis, April 1, 2008; 29(4): 816 - 823. [Abstract] [Full Text] [PDF]

				U. Peters, M. F. Leitzmann, N. Chatterjee, Y. Wang, D. Albanes, E. P. Gelmann, M. D. Friesen, E. Riboli, and R. B. Hayes Serum Lycopene, Other Carotenoids, and Prostate Cancer Risk: a Nested Case-Control Study in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Cancer Epidemiol. Biomarkers Prev., May 1, 2007; 16(5): 962 - 968. [Abstract] [Full Text] [PDF]

				H. D. Sesso, J. E. Buring, S. M. Zhang, E. P. Norkus, and J. M. Gaziano Dietary and Plasma Lycopene and the Risk of Breast Cancer Cancer Epidemiol. Biomarkers Prev., May 1, 2005; 14(5): 1074 - 1081. [Abstract] [Full Text] [PDF]

				H. L. Hantz, L. F. Young, and K. R. Martin Physiologically Attainable Concentrations of Lycopene Induce Mitochondrial Apoptosis in LNCaP Human Prostate Cancer Cells Experimental Biology and Medicine, March 1, 2005; 230(3): 171 - 179. [Abstract] [Full Text] [PDF]

				K. Wu, J. W. Erdman Jr., S. J. Schwartz, E. A. Platz, M. Leitzmann, S. K. Clinton, V. DeGroff, W. C. Willett, and E. Giovannucci Plasma and Dietary Carotenoids, and the Risk of Prostate Cancer: A Nested Case-Control Study Cancer Epidemiol. Biomarkers Prev., February 1, 2004; 13(2): 260 - 269. [Abstract] [Full Text] [PDF]